Rapid and accurate diagnostic testing is critical for effective management of infectious and non-infectious diseases, particularly in an era of emerging pathogens and antimicrobial resistance. Traditional methods such as microscopy, culture, and serology continue to serve as valuable tools; however, their limitations in speed and sensitivity have driven the evolution of advanced diagnostic techniques. Recent decades have seen the integration of molecular biology, immunology, proteomics, nanotechnology, and artificial intelligence (AI) into diagnostic platforms. Innovations including polymerase chain reaction (PCR), next-generation sequencing (NGS), CRISPR-based diagnostics, biosensors, and digital pathology are transforming laboratory medicine into a faster, more precise, and patient-centered discipline. These advancements are not only improving turnaround time but also enabling decentralized testing in remote and resource-limited settings, thereby expanding access to high-quality healthcare. Furthermore, rapid diagnostics have been shown to reduce healthcare costs by minimizing unnecessary hospital stays and ensuring timely initiation of targeted therapy. This review highlights key developments in diagnostic technologies, their clinical applications, challenges in global implementation, and future prospects for advancing personalized and precision medicine.
A et al. (Fri,) studied this question.